Orphan Drug & Rare Disease - Accelerating access to therapeutic innovation

Presentation

Organiser(s)

Training area(s)

  • Clinical investigation (general framework and/or pathology-specific)
  • Methodology

Langue :

English

  • Continuing education

Description

This training course aims to raise awareness among clinical research actors on the specificities of the development of drugs for rare diseases and to provide tools and solutions for clinical research professionals and project leaders:

  • - Identify tools for drug development,
  • - Consolidate practices,
  • - Understand the issues.

Incoming session

Aucune session à venir.

Ratings

Note moyenne de la formation : 8.0/10

Meriem EL JANI

8.2/10

le

05/07/2022

Orphan Drug & Rare Disease - Accelerating access to therapeutic innovation - 2017 (Edition 4)

Content of the training course

10/10

Teaching quality

8/10

General organisation of the training course

8/10

Application of the training course

8/10

Global satisfaction level

8/10

Valuation of the traing course

7/10

Ouvrir/Fermer

Anonymous

8.0/10

le

05/07/2022

Orphan Drug & Rare Disease - Accelerating access to therapeutic innovation - 2017 (Edition 4)

Content of the training course

9/10

Teaching quality

8/10

General organisation of the training course

10/10

Application of the training course

7/10

Global satisfaction level

9/10

Valuation of the traing course

5/10

Ouvrir/Fermer

Anonymous

8.0/10

le

05/07/2022

Orphan Drug & Rare Disease - Accelerating access to therapeutic innovation - 2017 (Edition 4)

Content of the training course

7/10

Teaching quality

8/10

General organisation of the training course

10/10

Application of the training course

9/10

Global satisfaction level

8/10

Valuation of the traing course

6/10

Ouvrir/Fermer

Anonymous

8.7/10

le

05/07/2022

Orphan Drug & Rare Disease - Accelerating access to therapeutic innovation - 2017 (Edition 4)

Content of the training course

9/10

Teaching quality

9/10

General organisation of the training course

9/10

Application of the training course

9/10

Global satisfaction level

9/10

Valuation of the traing course

7/10

Ouvrir/Fermer

Anonymous

8.0/10

le

05/07/2022

Orphan Drug & Rare Disease - Accelerating access to therapeutic innovation - 2017 (Edition 4)

Les intervenants sont très bons. Les sujets traités sont intéressants et d'actualité.

Content of the training course

8/10

Teaching quality

8/10

General organisation of the training course

8/10

Application of the training course

8/10

Global satisfaction level

8/10

Valuation of the traing course

8/10

Ouvrir/Fermer

Share

Updated on 22 September 2022